ABSTRACT
ß-Carotene 15,15'-monooxygenase (CMO1, BCMO1) converts ß-carotene to retinaldehyde (retinal) and is a key enzyme in vitamin A metabolism. CMO1 activity is robust in the intestine and liver, where cmo1 gene transcription may be subject to negative feedback by accumulation of its metabolic products. Evidence from CMO1 null animals also indicates that non-gastrointestinal CMO1 may be required for tissue-specific conversion of ß-carotene into vitamin A. The aim of this study was to investigate the effects of the enzymatic substrate, ß-carotene, on regulation of CMO1 in a cell model of human alveolar pneumocytes. We demonstrate that CMO1 is expressed in human alveolar epithelial (A549) cells and converts ß-carotene into retinal and biologically active retinoic acids (RA). Exposure to ß-carotene suppresses CMO1 expression at both mRNA and protein levels. ß-Carotene, but not all-trans RA, decreases CMO1 promoter activity in a time- and dosage-dependent manner. This ß-carotene-mediated inhibition of CMO1 expression results from decreased binding of peroxisome proliferator-activated receptor γ (PPARγ) and retinoid X receptor α (RXRα) in the CMO1 promoter. ß-Carotene treatment also antagonizes PPARγ activity in HEK293 cells that stably express CMO1 wild-type, but not in cells that express the CMO1 mutant or vector alone. These findings have implications for local vitamin A synthesis in the lung, especially during systemic vitamin A insufficiency and may also help to explain, in part, the mechanism underlying the increased lung cancer risk upon ß-carotene supplementation in smokers.
Subject(s)
Gene Expression Regulation, Enzymologic , Pulmonary Alveoli/enzymology , Respiratory Mucosa/metabolism , beta Carotene/physiology , beta-Carotene 15,15'-Monooxygenase/genetics , Cell Line, Tumor , Down-Regulation/genetics , HEK293 Cells , Humans , PPAR gamma/antagonists & inhibitors , PPAR gamma/genetics , PPAR gamma/metabolism , Protein Binding/genetics , Pulmonary Alveoli/pathology , Pulmonary Alveoli/physiology , Respiratory Mucosa/enzymology , Respiratory Mucosa/pathology , Up-Regulation/genetics , beta Carotene/metabolism , beta-Carotene 15,15'-Monooxygenase/antagonists & inhibitors , beta-Carotene 15,15'-Monooxygenase/biosynthesisABSTRACT
An ongoing controversy exists on beneficial versus harmful effects of high beta-carotene (BC) intake, especially for the lung. To elucidate potential mechanisms, we studied effects of BC on lung gene expression. We used a beta-carotene 15,15'-monooxygenase 1 (Bcmo1) knockout mouse (Bcmo1(-/-)) model, unable to convert BC to retinoids, and wild-type mice (Bcmo1(+/+)) mice to dissect the effects of intact BC from effects of BC metabolites. As expected, BC supplementation resulted in a higher BC accumulation in lungs of Bcmo1(-/-) mice than in lungs of Bcmo1(+/+) mice. Whole mouse genome transcriptome analysis on lung tissue revealed that more genes were regulated in Bcmo1(-/-) mice than Bcmo1(+/+) mice upon BC supplementation. Frizzled homolog 6 (Fzd6) and collagen triple helix repeat containing 1 (Cthrc1) were significantly downregulated (fold changes -2.99 and -2.60, respectively, false discovery rate < 0.05) by BC in Bcmo1(-/-). Moreover, many olfactory receptors and many members of the protocadherin family were upregulated. Since both olfactory receptors and protocadherins have an important function in sensory nerves and Fzd6 and Cthrc1 are important in stem cell development, we hypothesize that BC might have an effect on the highly innervated pulmonary neuroendocrine cell (PNEC) cluster. PNECs are highly associated with sensory nerves and are important cells in the control of stem cells. A role for BC in the innervated PNEC cluster might be of particular importance in smoke-induced carcinogenesis since PNEC-derived lung cancer is highly associated with tobacco smoke.
Subject(s)
Cadherins/genetics , Extracellular Matrix Proteins/genetics , Frizzled Receptors/genetics , Lung/physiology , Receptors, G-Protein-Coupled/genetics , Receptors, Odorant/genetics , beta Carotene/physiology , beta-Carotene 15,15'-Monooxygenase/deficiency , Animals , Carotenoids/isolation & purification , DNA Primers , Diet , Gene Amplification , Genome , Lung/cytology , Lung/drug effects , Lung/pathology , Male , Mice , Mice, Knockout , Oligonucleotide Array Sequence Analysis , RNA/genetics , RNA/isolation & purification , Retinoids/isolation & purification , Up-Regulation , beta Carotene/administration & dosage , beta Carotene/pharmacologyABSTRACT
DNA methylation is one of the important mechanisms regulating gene expression. Since beta-carotene (BC) was shown to have pro-chemotactic activity and stimulates expression of pro-angiogenic genes, this study was undertaken to define the possible changes in DNA methylation in endothelial cell and its progenitors in the presence of BC. The culture medium for human umbilical vein endothelial cells (HUVEC) and endothelial progenitor cells (EPC) was supplemented with BC (1 - 10 microM) with the presence of arachidonic acid (AA) (3 microM). Global DNA methylation tended to be lower in both endothelial cell lines, after incubation with BC and AA. HUVEC incubated with AA demonstrated the lowest DNA methylation. The decrease of DNA methylation in EPC, induced by BC, was concentration-dependent. The microarray study revealed, that the angiogenesis and homing-related genes were mostly influenced by BC and AA in investigated cells. Our results indicate that BC and AA-induced DNA hypomethylation in EPC and HUVEC, might be a mechanism which may alter gene expression in endothelial cells what in certain conditions may be connected with the suggested pro-malignant effect of this compounds.
Subject(s)
Angiogenesis Inducing Agents/pharmacology , Arachidonic Acid/pharmacology , Chemotaxis/drug effects , DNA Methylation , Endothelial Cells/drug effects , Stem Cells/drug effects , beta Carotene/pharmacology , Analysis of Variance , Arachidonic Acid/physiology , Cell Line , Cell Proliferation , Chromatography, High Pressure Liquid , Endothelial Cells/physiology , Endothelium, Vascular/cytology , Gene Expression Regulation , Humans , Oligonucleotide Array Sequence Analysis , Stem Cells/physiology , beta Carotene/physiologyABSTRACT
Carotenoids are important for various functions during chick development. Since these pigments cannot be synthesized, they can be considered limited resources that the mother optimally allocates between herself and her offspring (maternal effect). Some studies have examined the effects of carotenoids on growth and immune function but little is known about their role in behaviour. In this study of the grey partridge, we conducted two supplementation experiments: (1) laying females were fed with beta-carotene enriched or impoverished diets; (2) chicks were fed directly with beta-carotene enriched or impoverished diets. We then evaluated the effects of this carotenoid on chick growth, immunocompetence and anti-predator behaviour (reactions to a raptor model). In the first experiment, the beta-carotene enriched diet given to mothers did not cause any difference in chick physiology. In the second experiment, beta-carotene supplementation of chicks had a significant beneficial effect on their growth and immune response, although their behavioural reactions did not differ in relation to the diet. Therefore, beta-carotene supplementation had beneficial effects on growth and immunocompetence only when directly supplied to chicks. The beneficial effect reported in other species for begging or pecking behaviours was not confirmed for the anti-predator behaviour of grey partridge chicks.
Subject(s)
Behavior, Animal/physiology , Escape Reaction/physiology , Galliformes/growth & development , Immunity, Cellular/physiology , beta Carotene/physiology , Analysis of Variance , Animal Feed , Animals , Dietary Supplements , Female , Galliformes/immunology , Immunocompetence/physiology , Male , Ovum/physiology , beta Carotene/administration & dosageABSTRACT
Since it has to be expected that individuals exposed to oxidative stress who take supplements of beta-carotene are simultaneously exposed to both beta-carotene cleavage products (CPs) and oxidative stress, and both exposures have been demonstrated to cause genotoxic effects in primary rat hepatocytes, cyto- and genotoxic effects on primary rat hepatocytes after supplementation of the medium with increasing concentrations of a CP mixture during exposure to oxidative stress by treatment with either DMNQ (2,3-dimethoxy-1,4-naphthoquinone) or hypoxia/reoxygenation (Hy/Reox) was investigated. The cytological endpoints analysed were the mitotic indices, the percentages of apoptotic and necrotic cells, the percentages of micronucleated (MN) cells and the number of chromosomal aberrations (CAs) and sister chromatid exchanges (SCE). The results obtained clearly demonstrate that the CP mixture enhances the genotoxic effects of oxidative stress exposure, whereas it had no effect at all on the endpoints of cytotoxicity studied. These results further support the hypothesis that CP might be responsible for the reported carcinogenic response in the beta-CArotene and Retinol Efficacy Trial (CARET) and Alpha-Tocopherol Beta-carotene Cancer prevention (ATBC) chemoprevention trials.
Subject(s)
Hepatocytes/metabolism , beta Carotene/physiology , Animals , Chromosome Aberrations , DNA Damage , Dose-Response Relationship, Drug , Female , Hypoxia , Metaphase , Naphthoquinones/pharmacology , Oxidative Stress , Oxygen/metabolism , Rats , Rats, Inbred F344 , beta Carotene/metabolismABSTRACT
The macular pigments are predominantly composed of three carotenoids: lutein, zeaxanthin, and meso-zeaxanthin. These carotenoids are concentrated and distributed in a selective manner. The properties of these pigments are further explored along with their methods of uptake, stabilization, and storage. The dual nature of these pigments as filters and antioxidants are elaborated upon in relation to their protective effects upon the macula, specifically in age-related macular degeneration. Evidence suggests that increased levels of macular pigment are correlated with a decreased risk of age-related macular degeneration. Many have sought to exploit this therapeutic relation. Studies reveal that oral supplementation with lutein and zeaxanthin can increase the levels of macular pigments in the retina and plasma. The effects of such supplementation on actual ocular function have yet to be fully addressed. New and standardized methods of assessing macular pigment density are discussed and future areas of research to further our understanding of macular xanthophylls as they pertain to age-related macular degeneration are highlighted.
Subject(s)
Macula Lutea/metabolism , Retinal Pigments/physiology , Xanthophylls/physiology , beta Carotene/analogs & derivatives , Humans , Lutein/analysis , Lutein/physiology , Macula Lutea/chemistry , Retinal Pigments/analysis , Xanthophylls/analysis , Zeaxanthins , beta Carotene/analysis , beta Carotene/physiologyABSTRACT
BACKGROUND: The primary role of polymorphonuclear neutrophils (PMNs) is to destroy pathogenic microorganisms after phagocytosis by producing reactive oxygen species (ROS) and toxic molecules. However, PMNs produce sufficient amounts of ROS during an oxidative burst to be autotoxic and detrimental to their own functions and to possibly cause DNA damage, protein and lipid oxidation and cell membrane destructuration. OBJECTIVE: The aim of this study was to investigate in vivo the role of the antioxidant capacities of carotenoids in modulating ROS content in PMNs during oxidative burst. Moreover to investigate the direct or indirect effect of carotenoids, the modification of PMN ROS content was explored after in vitro supplementation with beta-carotene or lycopene, chosen taking account of their vitamin A and no vitamin A precursor effect, respectively. DESIGN: In vivo study: Venous blood was collected from 10 healthy male volunteers and ROS production from phorbol myristate acetate (PMA)-stimulated PMNs was determined, by flow cytometry using the fluorescent dye dihydrorhodamine 123, at baseline, after 3 weeks of carotenoid depletion (carotenoid intake limited to 25% of usual intake) and after 5 weeks of carotenoid repletion (30 mg beta-carotene, 15 mg lycopene and 9 mg lutein per day). In vitro study: ROS content in PMA-stimulated PMNs isolated from carotenoid depleted subjects and controls was quantified after an in vitro enrichment with beta-carotene (1 micromol/L) or lycopene (0.3 micromol/L). RESULTS: In vivo carotenoid depletion increased PMN H2O2 content after PMA activation by 38% (p < 0.05 vs baseline),while supplementation for 5 weeks restored basal H2O2 generation (p < 0.05 vs depletion). Although H2O2 measurement in PMNs from non-depleted subjects was not affected by an in vitro supply with beta-carotene or lycopene, a significant decrease in H2O2 content by 78.9 % and 81.2%, respectively, was observed in PMNs from carotenoid depleted subjects (p < 0.01 vs depleted control subjects). CONCLUSIONS: The carotenoid ROS quenching capacities control both in vivo and in vitro the PMNs ROS generation and probably protect these cells against DNA, membrane lipid and protein damages during oxidative burst. Moreover, these effects appear independent from the metabolic conversion of carotenoids to vitamin A.
Subject(s)
Antioxidants/physiology , Carotenoids/pharmacology , Neutrophils/drug effects , Reactive Oxygen Species/metabolism , Respiratory Burst/drug effects , Antioxidants/pharmacology , Carotenoids/blood , Carotenoids/physiology , Flow Cytometry , Humans , Hydrogen Peroxide/analysis , Hydrogen Peroxide/metabolism , In Vitro Techniques , Lycopene , Male , Middle Aged , Neutrophils/metabolism , Respiratory Burst/physiology , beta Carotene/pharmacology , beta Carotene/physiologyABSTRACT
Human intervention trials have suggested that supplemental beta-carotene resulted in more cancer in smokers, whereas it was protective in non-smokers. However, the mechanisms underlying these effects are still unknown. The aim of this study was to evaluate the effects of an association of cigarette smoke condensate (tar) and beta-carotene on DNA oxidative damage and molecular pathways involved in cell cycle progression and apoptosis in cultured cells. In RAT-1 fibroblasts, tar caused increased levels of 8-hydroxyl-2'-deoxyguanosine (8-OHdG) and this effect was enhanced by the concomitant presence of beta-carotene (0.5-4.0 microM) in a dose- and time-dependent manner. In contrast, beta-carotene alone did not significantly modify it. Fibroblasts treated with tar alone decreased their cell growth with respect to control cells through an arrest of cell cycle progression in the G0/G1 phase and an induction of apoptosis. These effects were accompanied by an increased expression of p53, p21 and Bax and by a decreased expression of cyclin D1. In contrast, fibroblasts treated with tar and beta-carotene, after an initial arrest of cell growth at 12 h, re-entered in cell cycle and were unable to undergo apoptosis at 36 h. Concomitantly, their p53 expression, after an increase at 12 h, progressively returned at basal levels at 36 h by a mechanism independent of Mdm2. Such a decrease was followed by a decrease in p21 and Bax expression and by an increase in cyclin D1 expression. Moreover, the presence of the carotenoid remarkably enhanced cyclooxygenase-2 expression induced by tar. During tar treatment, a depletion of beta-carotene was observed in fibroblasts. The effects of tar and beta-carotene on 8-OHdG levels, cell growth and apoptosis were also observed in Mv1Lu lung, MCF-7 mammary, Hep-2 larynx and LS-174 colon cancer cells. This study supports the evidence for potential detrimental effects of an association between beta-carotene and cigarette smoke condensate.
Subject(s)
DNA Damage , Deoxyguanosine/analogs & derivatives , Nicotiana/adverse effects , Oxygen/metabolism , Proto-Oncogene Proteins c-bcl-2 , Tumor Suppressor Protein p53/physiology , beta Carotene/physiology , 8-Hydroxy-2'-Deoxyguanosine , Animals , Apoptosis , Blotting, Western , Cell Cycle/drug effects , Cell Division , Cell Line, Tumor , Cells, Cultured , Cyclin D1/biosynthesis , Deoxyguanosine/biosynthesis , Dose-Response Relationship, Drug , Fibroblasts/drug effects , Fibroblasts/metabolism , G1 Phase , Humans , Mice , Oxidative Stress , Proto-Oncogene Proteins/metabolism , Rats , Resting Phase, Cell Cycle , Smoking/adverse effects , Time Factors , Tumor Suppressor Protein p53/metabolism , bcl-2-Associated X ProteinABSTRACT
Dr. James Allen Olson helped us to define the role of beta-carotene in human health by categorizing these as "functions, actions and associations." In the last decade, significant research has shown that beta-carotene acts as an antioxidant in biologically relevant systems, affects several aspects of human immune function and higher intake/serum levels are associated with improvements in certain physiological functions such as lung function. The unexpected findings of increased lung cancer in beta-carotene supplemented smokers in the ATBC and CARET intervention studies have resulted in the need for expanded research efforts to define the mechanism(s) of action of beta-carotene. Recent survey data as well as laboratory animal studies continue to find an inverse association between beta-carotene and cancer risk. Because beta-carotene is the major source of vitamin A for the majority of the world's population, it is critical to define the safe levels of intake from foods and supplements.
Subject(s)
beta Carotene/pharmacology , Animals , Anticarcinogenic Agents , Antioxidants/pharmacology , Carcinogens , Dietary Supplements , Female , Humans , Immunity/drug effects , Lung/physiology , Lung Neoplasms , Male , Middle Aged , Smoking , beta Carotene/blood , beta Carotene/physiologyABSTRACT
The carotenoids lutein and zeaxanthin are found in the macula in high concentrations and may play a role in the pathogenesis of age-related macular degeneration (ARMD). Lutein and zeaxanthin may protect the macula and photoreceptor outer segments throughout the retina from oxidative stress and play a role in an antioxidant cascade that safely disarms the energy of reactive oxygen species. Although lutein and zeaxanthin are not essential nutrients, studies are beginning to suggest that they fit the criteria for conditionally essential nutrients. Low plasma lutein and zeaxanthin concentrations or dietary intake are associated with low macular pigment density and increased risk of ARMD. Dietary deprivation of lutein and zeaxanthin in primates causes pathological changes in the macula. Should controlled clinical trials show lutein and/or zeaxanthin supplementation protects against the development or progression of ARMD and other eye diseases, then lutein and zeaxanthin could be considered as conditionally essential nutrients for humans.
Subject(s)
Lutein/physiology , Ocular Physiological Phenomena , beta Carotene/physiology , Aging , Antioxidants/pharmacology , Carotenoids/pharmacology , Dietary Supplements , Humans , Macular Degeneration/prevention & control , Models, Theoretical , Oxidative Stress , Retina/physiology , Xanthophylls , Zeaxanthins , beta Carotene/analogs & derivativesABSTRACT
Las formulaciones disponibles actualmente para uso dermatológico, basadas en sustancias antioxidantes tales como vitaminas C y E, entre otras, abundan con promesas de revertir el envejecimiento cutáneo. En el presente trabajo se realiza una revisión de los sistemas antioxidantes cutáneos, de la relación entre envejecimiento y daño oxidativo, así como de la evidencia disponible en cuanto al tratamiento con antioxidantes. La intención de este artículo es que el dermatólogo comprenda las bases fisiológicas de acción de los antioxidantes, para poder juzgar su utilidad con una mirada crítica (AU)
Subject(s)
Humans , Animals , Skin Aging , Antioxidants/physiology , Ascorbic Acid/therapeutic use , Vitamin E/therapeutic use , Skin/radiation effects , Reactive Oxygen Species , Ultraviolet Rays/adverse effects , Antioxidants/therapeutic use , Antioxidants/radiation effects , Ascorbic Acid/pharmacology , Ascorbic Acid/physiology , Vitamin E/pharmacology , Vitamin E/physiology , Skin/drug effects , Skin Physiological Phenomena , Superoxide Dismutase/physiology , Superoxide Dismutase/radiation effects , Catalase/physiology , Catalase/radiation effects , Peroxidase/physiology , Peroxidase/radiation effects , Glutathione Peroxidase/physiology , Glutathione Peroxidase/radiation effects , Glutathione Reductase/physiology , Glutathione Reductase/radiation effects , Glutathione Transferase/physiology , Glutathione Transferase/radiation effects , beta Carotene/physiology , beta Carotene/radiation effects , Ubiquinone/physiology , Ubiquinone/radiation effects , Ozone/adverse effects , Administration, Topical , Cosmetics , Clinical Trials as Topic , Interleukins/radiation effects , Sunlight/adverse effectsABSTRACT
The macular region of the primate retina is yellow in color due to the presence of the macular pigment, composed of two dietary xanthophylls, lutein and zeaxanthin, and another xanthophyll, meso-zeaxanthin. The latter is presumably formed from either lutein or zeaxanthin in the retina. By absorbing blue-light, the macular pigment protects the underlying photoreceptor cell layer from light damage, possibly initiated by the formation of reactive oxygen species during a photosensitized reaction. There is ample epidemiological evidence that the amount of macular pigment is inversely associated with the incidence of age-related macular degeneration, an irreversible process that is the major cause of blindness in the elderly. The macular pigment can be increased in primates by either increasing the intake of foods that are rich in lutein and zeaxanthin, such as dark-green leafy vegetables, or by supplementation with lutein or zeaxanthin. Although increasing the intake of lutein or zeaxanthin might prove to be protective against the development of age-related macular degeneration, a causative relationship has yet to be experimentally demonstrated.
Subject(s)
Cataract/diet therapy , Lutein/physiology , Macula Lutea/chemistry , Macular Degeneration/diet therapy , beta Carotene/analogs & derivatives , beta Carotene/physiology , Age Factors , Aging/physiology , Antioxidants/metabolism , Cataract/prevention & control , Humans , Lutein/administration & dosage , Lutein/chemistry , Macular Degeneration/prevention & control , Retina/drug effects , Retinal Pigments/analysis , Retinal Pigments/chemistry , Retinal Pigments/physiology , Risk Factors , Xanthophylls , Zeaxanthins , beta Carotene/administration & dosage , beta Carotene/chemistryABSTRACT
The growth of our knowledge of carotenoid biochemistry has opened new and divergent paths for research. The earliest role established for beta-carotene in animals was as a vitamin A precursor, a role it shares with several other pro-vitamin A carotenoids. Additional studies have continued to refine our understanding of this function. Because carotenoids are excellent scavengers of singlet oxygen and respectable scavengers for other reactive oxygen species, substantial work was done concerning their potential role as antioxidants. In an unexpected twist, the ability of radicals in cigarette smoke to degrade carotenoids might be responsible for the finding that high-dose dietary beta-carotene increased the incidence of lung cancer in smokers. A new role for the polar carotenoids lutein and zeaxanthin was identified, when those carotenoids were found to constitute the macular pigment (the yellow spot at the center of the human retina). Many different carotenoids can be metabolized to products with retinoid activity, which might affect gene expression and cell differentiation. The formation of retinoids from diverse carotenoids might account for a portion of their activities as anticancer agents. Studies of lycopene in prostate cancer prevention have been very promising, and clinical studies of lycopene are underway. Carotenoids have emerged as the best single tissue marker for a diet rich in fruits and vegetables, and measurements of plasma and tissue carotenoids have an important role in defining the optimal diets for humans.
Subject(s)
Carotenoids/physiology , Animals , Antioxidants , Carotenoids/chemistry , Carotenoids/therapeutic use , Fruit/chemistry , Humans , Lung Neoplasms/etiology , Lung Neoplasms/prevention & control , Macular Degeneration/prevention & control , Neoplasms/prevention & control , Reactive Oxygen Species , Smoking/adverse effects , Smoking/metabolism , Vegetables/chemistry , Vitamin A/chemistry , Vitamin A/physiology , Vitamin A/therapeutic use , beta Carotene/chemistry , beta Carotene/physiology , beta Carotene/therapeutic useSubject(s)
Carotenoids/physiology , Gallic Acid/analogs & derivatives , beta Carotene/physiology , Cardiovascular Diseases/prevention & control , Carotenoids/administration & dosage , Dietary Supplements , Gallic Acid/metabolism , Humans , Macular Degeneration/prevention & control , Neoplasms/prevention & control , beta Carotene/administration & dosageABSTRACT
Luteal cells were isolated from mid-luteal heifer ovaries by collagenase digestion. Cells were cultured with DMEM/Ham's F12 medium in serum pre-treated plastic culture dishes for periods of up to 11 days. As beta-carotene is almost completely insoluble in all polar solvents, it was added to cultures in either dimethyl sulphoxide (DMSO), tetrahydrofuran (THF) or as high-density lipoprotein (HDL) containing high or low beta-carotene concentrations. Medium was replaced after 24 h, thereafter medium was changed every 48 h. Treatment of cells with DMSO alone or with beta-carotene (5 micromol/l) in DMSO both resulted in significant (P<0.01) stimulation of progesterone production. beta-Carotene (5 micromol/l) in THF did not alter progesterone production but 50 micromol/l beta-carotene in THF resulted in significant inhibition (P<0.02) of progesterone production on days 3 and 7. Cultures were also supplemented with bovine HDL preparations containing equal concentrations of cholesterol (25 microg/ml) but high or low beta-carotene (12.4 or 0.44 microg/mg of cholesterol). Both HDL preparations significantly stimulated progesterone production (P<0. 001) but the high beta-carotene HDL was significantly (P<0.02) more effective than the low beta-carotene HDL. However, when given together with bovine luteinizing hormone (bLH) or dibutyryl cAMP (dbcAMP), the high beta-carotene HDL stimulated progesterone production less than did the low HDL (P<0.01). Uptake and depletion of beta-carotene by luteal cells were also examined in culture. beta-Carotene supplementation increased luteal cell beta-carotene from an initial level of 373 ng per 10(6) cells to 2030 ng per 10(6) cells by day 6. In contrast, the levels in control cells decreased to 14% of starting values during the same period. Cells treated with HDL containing high beta-carotene on day 1 or days 1 and 3 were then incubated with or without bLH or dbcAMP for a further 2 days to investigate the effect of bLH and dbcAMP on depletion of beta-carotene by luteal cells. beta-Carotene depletion in the luteal cells was significantly higher (P<0.05) in LH- and dbcAMP-treated cells than in the control cells in both groups. These results indicate that the use of solvents such as DMSO or THF may have undesirable effects due to alteration of cell membrane permeability. Supplementation with bLH or dbcAMP may increase the metabolism of beta-carotene in luteal cells. bLH or dbcAMP together with high beta-carotene HDL may, when combined with the effect of increased beta-carotene metabolism, give less stimulation than with low beta-carotene HDL.
Subject(s)
Cattle/physiology , Lipoproteins, HDL/physiology , Luteal Cells/physiology , Progesterone/biosynthesis , beta Carotene/physiology , Animals , Bucladesine/pharmacology , Chromatography, High Pressure Liquid/veterinary , Dimethyl Sulfoxide/pharmacology , Female , Furans/pharmacology , Luteal Cells/chemistry , Luteinizing Hormone/physiology , Male , Progesterone/analysisABSTRACT
BACKGROUND: Evidence indicates that different types of fat have different effects on the postprandial plasma triacylglycerol response. Therefore, the type of fat may influence the appearance of beta-carotene in postprandial triacylglycerol-rich lipoproteins, which is used as an indicator of intestinal beta-carotene absorption. OBJECTIVE: We compared in female subjects the appearance of beta-carotene in plasma triacylglycerol-rich lipoproteins after beta-carotene was ingested with a meal containing sunflower oil or beef tallow. DESIGN: Women (n = 11) each ingested 2 different vitamin A-free, fat-rich meals that were supplemented with beta-carotene (47 micromol) and contained equivalent amounts (60 g) of sunflower oil or beef tallow. Blood samples were collected hourly from 0 to 10 h; additional samples were collected at selected intervals until 528 h. In a subgroup of the women (n = 7), plasma chylomicrons and 3 subfractions of VLDLs were separated by cumulative rate ultracentrifugation. RESULTS: The appearance of beta-carotene in chylomicrons and in each VLDL subfraction was lower after ingestion with the meal containing sunflower oil than after ingestion with the meal containing beef tallow (P < 0.03). In chylomicrons, the area under the concentration-versus-time curve (AUC) for beta-carotene was 38.1 +/- 13.6% lower (P < 0.03); in contrast, the AUC for triacylglycerol was higher (P < 0.05) after the sunflower-oil-rich meal than after the beef-tallow-rich meal. CONCLUSIONS: Ingestion of beta-carotene with a meal rich in sunflower oil as compared with a meal rich in beef tallow results in lower appearance of beta-carotene and greater appearance of triacylglycerol in triacylglycerol-rich lipoproteins.
Subject(s)
Dietary Fats/metabolism , Intestinal Absorption/physiology , Lipoproteins/metabolism , beta Carotene/pharmacokinetics , Adult , Animals , Cattle , Chylomicrons/chemistry , Diterpenes , Fats/metabolism , Fatty Acids/metabolism , Female , Humans , Lipoproteins/blood , Lipoproteins/chemistry , Lipoproteins, LDL/chemistry , Lipoproteins, VLDL/chemistry , Plant Oils/metabolism , Postprandial Period , Retinyl Esters , Sunflower Oil , Triglycerides/blood , Ultracentrifugation , Vitamin A/analogs & derivatives , Vitamin A/metabolism , beta Carotene/blood , beta Carotene/physiologyABSTRACT
BACKGROUND: Fat-soluble vitamin E and carotenoids are regarded as being protective against chronic diseases. Little is known about the effect of dietary fat on the bioavailability of these compounds. OBJECTIVE: The objective of this study was to assess the effect of the amount of dietary fat on plasma concentrations of vitamin E and carotenoids after supplementation with these compounds. DESIGN: During two 7-d periods, 4 groups of 14-15 volunteers received daily, with a low-fat hot meal, 1 of 4 different supplements: vitamin E (50 mg), alpha- plus beta-carotene (8 mg), lutein esters (8 mg lutein), or placebo. The supplements were provided in a low- or high-fat spread supplied in random sequence during either of the 2 experimental periods. RESULTS: As anticipated, plasma concentrations of vitamin E, alpha- and beta-carotene, and lutein were significantly higher in the supplemented groups than in the placebo group. The amount of dietary fat consumed with the hot meal (3 or 36 g) did not affect the increases in plasma concentrations of vitamin E (20% increase with the low-fat spread and 23% increase with the high-fat spread) or alpha- and beta-carotene (315% and 139% with the low-fat spread and 226% and 108% with the high-fat spread). The plasma lutein response was higher when lutein esters were consumed with the high-fat spread (207% increase) than with the low-fat spread (88% increase). CONCLUSION: Optimal uptake of vitamin E and alpha- and beta-carotene requires a limited amount of fat whereas the amount of fat required for optimal intestinal uptake of lutein esters is higher. 2000;71:-93.
Subject(s)
Carotenoids/pharmacokinetics , Dietary Fats/metabolism , Lutein/pharmacokinetics , Vitamin E/pharmacokinetics , beta Carotene/pharmacokinetics , Adolescent , Adult , Aged , Biological Availability , Carotenoids/blood , Carotenoids/physiology , Cholesterol/blood , Cross-Over Studies , Cryptoxanthins , Esters , Female , Humans , Lutein/blood , Lycopene , Male , Middle Aged , Triglycerides/blood , Vitamin E/blood , Vitamin E/physiology , Xanthophylls , beta Carotene/analogs & derivatives , beta Carotene/blood , beta Carotene/physiologyABSTRACT
Vitamin E supplementation has been shown to contribute in immunoregulation, antibody production, and resistance to implanted tumors. Similarly beta-carotene has been shown to down-regulate growth factors which contribute towards proliferation of pre-malignant cells. We embarked upon a study to evaluate the effect of vitamin E and beta-carotene on natural killer (NK) cells, which perform tumor surveillance role in the mammalian body. Mouse splenocytes or human peripheral blood lymphocytes were used as NK cells with murine YAC-1 lymphoma or human K-562 lymphoma cells, respectively, as target cells. The NK cells were treated with vitamin E or beta-carotene while target cells were labeled with sodium 51chromate. Both cell types were then reacted for 4 hours. The NK cell tumorolytic activity was measured by the chromium release assay. Oral administration of alpha-tocopherol at a dose of 100 mg/d in mice showed a significant increase in NK cell activity. Similarly, treatment of NK cells with alpha-tocopherol in vitro at doses 0.5 mg/ml, 1-0 mg/ml, and 2.0 mg/ml increased the tumorolytic activity of NK cells. Tocotrienol showed a similar response at ten times lower dose. When NK cells were treated with varying concentrations of palm vitee (mixture of alpha-tocopherol and tocotrienol), maximum effect was observed at the dose mixture of 12 micrograms and 24 micrograms alpha-tocopherol and tocotrienol, respectively. When murine NK cells were treated in vitro with beta-carotene at doses ranging from 2 ng/mg to 200 ng/ml, a decrease in tumorolytic effect was observed. However, human NK cells after treatment with beta-carotene at doses ranging from 0.1 microgram/ml to 10 micrograms/ml showed a significant increase in tumorolytic function. NK cells were also obtained from mice that had been parenterally administered beta-carotene and alpha-tocopherol. These experiments showed no significant increase in the NK cell function.
Subject(s)
Killer Cells, Natural/drug effects , Vitamin E/pharmacology , beta Carotene/pharmacology , Animals , Chromium Radioisotopes , Humans , Killer Cells, Natural/physiology , Lymphocytes/physiology , Lymphoma/drug therapy , Lymphoma/physiopathology , Mice , Mice, Inbred BALB C , Spleen/cytology , Tumor Cells, Cultured , Vitamin E/physiology , beta Carotene/physiologyABSTRACT
Micronutrient deficiencies are common in HIV/AIDS, resulting from both malabsorption and virally-caused depletion. Beta carotene and selenium deficiencies, two of the most common nutrient deficiencies, are important due to their dual function as nutrients necessary for immune modulation and as antioxidants. Beta carotene deficiencies are common in all stages of HIV/AIDS and may signal malabsorption. Supplementation has been shown to affect specific T lymphocyte populations and decrease markers of lipoperoxides. Selenium levels are highly significant in predicting AIDS-related mortality; and the HIV virus manufactures selenoproteins that are involved in the regulation of viral replication, possibly depleting host levels of selenium. Supplementation trials with individual antioxidants have shown improvement in immunological parameters and decreased evidence of lipid peroxidation.
Subject(s)
Acquired Immunodeficiency Syndrome/metabolism , Antioxidants/therapeutic use , Selenium/deficiency , beta Carotene/deficiency , Acquired Immunodeficiency Syndrome/drug therapy , CD4 Lymphocyte Count/drug effects , Female , Humans , Pregnancy , Selenium/physiology , Selenium/therapeutic use , beta Carotene/physiology , beta Carotene/therapeutic useABSTRACT
Carotenoids are a family of pigments with at least 600 members. They derive from lycopene after steps of cyclisation, dehydrogenation and oxidation. It is their chemical structure that determines their physiochemical properties and, in part, their biological activities. About 50 carotenoids can be found in human diet and about 20 of them have been found in plasma and tissues. There is no RDA (Recommended Daily Allowance) for carotenoids. Quantities of carotenoids in diet are difficult to estimate, partly because methods used for the establishment of food composition tables were not specific and sensitive enough. Also, given values do not always take into account variations due to season and region of culture. Absorption of beta-carotene in humans has been the subject of numerous studies but only very little is known about other carotenoids. In general, absorption depends on bioavailability from the food matrix and solubility in micelles. After absorption through passive diffusion, carotenoids follow the chylomicrons metabolism. They are taken up by the liver and released in the blood stream in lipoproteins (VLDL). Carotenoids with no-substituted beta-ionone cycles (alpha and beta-carotene and beta-cryptoxanthin) have provitamin A activity. Highest activity has been found for all-trans beta-carotene. Not all steps of vitamin A biosynthesis and metabolism of other carotenoids have been clarified yet. Besides their provitamin A activity, carotenoids have numerous biological functions. They are efficient scavengers of free radicals, particularly of 1O2. In vitro they have been shown to protect LDL. However, results in vivo are inconsistent. Other functions include enhancement of gap junctions, immunomodulation and regulation of enzyme activity involved in carcinogenesis.